An angel group based in CA makes early-stage equity investments in a wide range of life science companies. The group invests primarily in California, but is open to investing out of state provided a round is being syndicated with a local angel group. The group does not rule out investing outside the USA, but has yet to do so. The group invests as individuals and allocation sizes are therefore highly varied, but are usually of about $200,000-$600,000; The group usually invests in rounds seeking $3 million or less. The group is interested in syndicating rounds with other angel groups.
The group is interested in investing in therapeutics (including small molecules, biologics and cell and gene therapies), life science tools, genomics, diagnostics, medical devices, and healthcare IT. The group requires that companies have proof of concept data, such as preclinical test results or a completed prototype of their product; the group does not invest in discovery-stage or pre-prototype companies. The firm is open to investing in any indication or area of technology.
The group prefers to invest in opportunities where an exit is possible in 3-5 years. If outside California, the group requires that companies have built a relationship with an angel group in their local area. For healthcare IT companies, the group favors companies that have already attained revenue.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment